MacroGenics
MGNX
127 hedge funds and large institutions have $794M invested in MacroGenics in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 53 increasing their positions, 32 reducing their positions, and 25 closing their positions.
182% more call options, than puts
Call options by funds: $155K | Put options by funds: $55K
66% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 32
4% less funds holding
Funds holding: 132 → 127 (-5)
11.06% less ownership
Funds ownership: 102.17% → 91.1% (-11%)
16% less capital invested
Capital invested by funds: $949M → $794M (-$155M)
20% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 25
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
+$12.2M |
| 2 |
State Street
Boston,
Massachusetts
|
+$10.7M |
| 3 |
BlackRock
New York
|
+$10.5M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.36M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$6.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$21.5M |
| 2 |
Millennium Management
New York
|
-$10.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.33M |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$4.97M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.77M |
MGNX Hedge Fund Activity: Q2 2018 in Review
127 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q2 2018, worth a combined $794M — down 16% from $949M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of MGNX and 20 opened new positions — a net loss of 5 holders — while 32 trimmed existing stakes and 53 added.
The largest buyer was VOYA Investment Management, adding an estimated $12.2M. The largest seller was Boxer Capital, cutting an estimated $21.5M.
- 127 institutional investors held MacroGenics (MGNX) as of Q2 2018, down from 132 in Q1 2018.
- Funds reported $794M of MacroGenics stock for Q2 2018, down 16% quarter-over-quarter.
- 20 funds opened new MacroGenics positions in Q2 2018 and 25 closed out, a net change of -5 holders.
- The largest MacroGenics buyer in Q2 2018 was VOYA Investment Management, an estimated $12.2M added.
- The largest MacroGenics seller in Q2 2018 was Boxer Capital, an estimated $21.5M sold.
Based on aggregated 13F filings for Q2 2018.